Bausch Health - M&A Summary and Business Overview

Life ScienceCompany

Bausch Health M&A Summary

Bausch Health has acquired 40 companies, including 1 in the last 5 years. A total of 13 acquisitions came from private equity firms. It has also divested 10 assets.

Bausch Health’s largest acquisition to date was in 2015, when it acquired Salix Pharmaceuticals for $14.5B. It’s largest disclosed sale occurred in 2017, when it sold Inova Pharmaceuticals Pte to Pacific Equity Partners for $930M. Bausch Health has acquired in 10 different US states, and 12 countries. The Company’s most targeted sectors include life science (60%) and consumer products (18%).

Bausch Health Business Overview

Where is Bausch Health headquartered?

Bausch Health is headquartered in Laval, Quebec.

What is Bausch Health’s revenue?

Bausch Health disclosed revenue of 8,757M USD for 2023 and 8,124M USD for 2022.

How many employees does Bausch Health have?

Bausch Health has 20,270 employees.

What sector is Bausch Health in?

Bausch Health is a life science company.

M&A Summary

  • M&A Total Activity45
    • M&A Buy Activity35
    • M&A Sell Activity10
  • Total Sectors Invested 4
  • Total Countries Invested 12
  • M&A Buy/Sell Connections 34
  • M&A Advisors 17

Bausch Health

Bausch Health Companies, Inc.

2150 St. Elzear Boulevard West,
Laval, Quebec H7L 4A8
Canada,
(514) 744-6792
www.bauschhealth.com

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 35 - - - - - 35
vol $32.8B $32.8B
Sell (0.2/yr) # 9 1 - - - - 10
vol $2.0B $740M $2.7B
  45

Most Recent M&A

Company Date Value Type
Amoun Pharmaceutical Company S.A.E. 2021-03-31 740M USD Divestiture
Cairo, Egypt · www.amoun.com
Allegro Ophthalmics LLC - Ophthalmology Assets 2020-09-21 - Divestiture
San Juan Capistrano, California
Synergy Pharmaceuticals, Inc. - Certain Assets 2019-02-26 195M USD Divestiture
New York, New York
Obagi Medical Products, Inc. 2017-11-10 190M USD Divestiture
Long Beach, California · www.obagi.com
Inova Pharmaceuticals (Singapore) Pte Ltd. 2017-06-08 930M USD Divestiture
Singapore, Singapore · www.inovapharma.com
CeraVe 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.cerave.com
Acnefree 2017-01-10 - Divestiture
Bridgewater, New Jersey · www.acnefree.com
Valeant Pharmaceuticals - AMBI Skincare 2017-01-10 - Divestiture
Bridgewater, New Jersey
Dendreon Pharmaceuticals, Inc. 2017-01-09 820M USD Divestiture
Seattle, Washington · www.dendreon.com
Synergetics USA, Inc. 2015-10-15 - Add-on Acquisition
O’Fallon, Montana · www.synergeticsusa.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Bausch & Lomb, Inc. 2013-05-27 Trukera Medical 2024-07-23 6
Rochester, New York · www.bausch.com Southlake, Texas · www.trukera.com
Bausch & Lomb, Inc. 2013-05-27 Xiidra 2023-06-30 5
Rochester, New York · www.bausch.com Basel, Switzerland · www.xiidra.com
Bausch & Lomb, Inc. 2013-05-27 Acufocus, Inc. 2023-01-17 4
Rochester, New York · www.bausch.com Irvine, California · www.acufocus.com
Bausch & Lomb, Inc. 2013-05-27 Allegro Ophthalmics LLC - Ophthalmology Assets 2020-09-21 3
Rochester, New York · www.bausch.com San Juan Capistrano, California
Synergetics USA, Inc. 2015-10-15 Synergetics USA, Inc. - Neuro Portfolio 2016-02-10 1
O’Fallon, Montana · www.synergeticsusa.com O’Fallon, Montana

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 21 (60%) 21.8B (66%) 3 (30%) 1.7B (64%)
Consumer Products 6 (17%) 782M (2%) 5 (50%) 190M (7%)
Medical Products 6 (17%) 10.2B (31%) 1 (10%) 740M (27%)
Healthcare Services 2 (6%) 20M (< 1%) - -
Technology Hardware - - 1 (10%) 49M (2%)
Total 35 $32.8B 10 $2.7B

By Geo

State/Country Buy Value Sell Value
United States 22 30.6B 7 1.1B
  California 6 1.3B 2 239M
  New Jersey 5 1.1B 3 -
  New York 3 8.9B - -
  North Carolina 2 15.5B - -
  Washington 1 400M 1 820M
  Montana 1 - - -
  Florida 1 28M - -
  Arizona 1 2.6B - -
  Rhode Island 1 475M - -
  Pennsylvania 1 312M - -
Canada 3 9M - -
  Ontario 2 9M - -
  Quebec 1 - - -
Egypt 1 800M 1 740M
Singapore 1 498M 1 930M
Australia 1 - - -
Austria 1 - - -
Brazil 1 41M - -
India - - 1 -
Lithuania 1 - - -
Mexico 1 - - -
Russia 1 163M - -
Switzerland 1 394M - -
United Kingdom 1 300M - -
Domestic 3 (9%) 9M (< 1%) - -
Cross-border 32 (91%) 32.8B (100%) 10 (100%) 2.7B (100%)
Total 35 $32.8B 10 $2.7B

Top M&A Advisors

Financial Deals
Morgan Stanley
2
Goldman Sachs
2
Centerview Partners
1
Legal Deals
Skadden, Arps, Slate, Meagher & Flom
6
Sullivan & Cromwell
3
Wachtell, Lipton, Rosen & Katz
2

Deal Values

buy # Total
> $1B 4 $26.8B
$100M to $1B 16 $5.8B
< $100M 7 $215M
TOTAL $32.8B
Largest Salix Pharmaceuticals Ltd.
$14.5B (2015-02-22)
sell # Total
$100M to $1B 4 $2.7B
< $100M 1 $49M
TOTAL $2.7B
Largest Inova Pharmaceuticals (Singapore) Pte Ltd.
$930M (2017-06-08)

M&A Connections

Deals
Acquired from
Investor(s)
23%
8 (23%)
Strategic(s)
29%
10 (29%)
Divested to
Investor(s)
30%
3 (30%)
Strategic(s)
70%
7 (70%)

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Bausch Health

Life Science Companies